<?xml version="1.0" encoding="UTF-8"?>
<p>We first evaluated the feasibility of virtual screening using a closely related protein, the SARS Mpro (96â€‰% of sequence identity,) for which different series of noncovalent inhibitors with low micromolar to nanomolar acitivity have been discovered.
 <xref rid="minf202000028-bib-0037" ref-type="ref">37</xref>
</p>
